Global Senior Commercial Director, Hematology

AstraZeneca•Gaithersburg, MD

1d•$231,989 - $347,983

About The Position

The Global Commercial Director, Hematology – Customer Engagement & Advocacy is a key member of the Global Hematology leadership and commercial teams, accountable for shaping and advancing the Franchise Customer Engagement and Advocacy strategy across the Hematology portfolio. The role leads a therapeutic-area and portfolio approach across CLL, NHL and Multiple Myeloma, spanning established brands, emerging assets and early pipeline, and evolves Customer Engagement from individual brand initiatives toward an integrated Franchise model. The role is accountable for building strong external partnerships, developing impactful Advocacy strategies, transforming the customer experience through a OneAZ approach, and leveraging major scientific and external engagement opportunities to strengthen AZ's leadership and generate actionable insights. The role also leads the Advocacy capability, establishing the frameworks, tools and ways of working required to scale effective Customer Engagement across Global, Regions and Markets. Reporting to the Global Hematology Franchise, the role works closely with Commercial, Medical, R&D, Insights & Analytics, Market Access, Communications, Regions and Markets to deliver strategic and measurable impact across the Hematology portfolio.

Requirements

Significant experience in global pharmaceutical commercial, marketing, Customer Engagement or Advocacy roles, preferably in Oncology or Hematology.
Proven track record of developing and delivering global strategies across multiple markets, brands or portfolio assets.
Demonstrated experience building strong relationships with senior external experts and stakeholders.
Strong strategic thinking, business acumen and ability to translate customer and external insights into action.
Proven ability to lead through a complex global matrix and influence without authority.
Strong cross-functional experience with Commercial, Medical, R&D, Insights, Market Access and/or regional teams.
Excellent communication, influencing and stakeholder management skills.
Bachelor's Degree in relevant field.
10+ years' experience in pharmaceutical development and/or commercialisation.

Nice To Haves

Experience in Hematology and/or Oncology, ideally across multiple therapeutic areas or assets.
Experience leading Advocacy, Key Expert Engagement, Customer Engagement and/or congress strategy.
Strong understanding of the clinical and scientific environment and ability to engage credibly with external experts.
Experience building capabilities, operating models or new ways of working across a global organization.
Experience supporting launches, major data milestones or lifecycle strategies.
Advanced degree or MBA.

Responsibilities

Lead Global Hematology Customer Engagement Strategy: Define and evolve the Franchise-wide Customer Engagement strategy across CLL, NHL and Multiple Myeloma, spanning current and future portfolio priorities. Translate therapeutic area and portfolio priorities into differentiated Customer Engagement strategies, balancing global consistency with local relevance. Establish clear priorities, governance and ways of working across Global, Regions and Markets. Generate and translate customer insights into actionable inputs for Franchise, therapeutic area, brand and development strategies. Ensure strong integration across Commercial, Medical, R&D, Insights & Analytics and Market Access.
Lead Global Hematology Advocacy Strategy & Impact: Define and lead the Hematology Franchise Advocacy strategy, in partnership with Regions and Markets. Translate strategic priorities into clear Advocacy objectives. Lead KEE mapping, segmentation and prioritization, including identification of priority experts and emerging leaders. Support development of market and individual KEE engagement plans, with clear objectives, actions and desired outcomes. Define and track Advocacy KPIs and impact measures, using insights and performance to refine priorities and plans. Leverage Advocacy and KEE engagement to strengthen strategy, generate insights and build AZ as a preferred partner in Hematology.
Transform the Hematology Customer Experience: Enable a OneAZ approach that provides customers with a consistent, coordinated and differentiated experience across AZ stakeholders. Establish seamless cross-functional ways of working that remove barriers to effective customer collaboration. Improve prioritization, coordination and transparency of customer engagement across Global, Regions and Markets. Deploy tools, platforms and processes that enable a personalized and differentiated customer experience.
Lead Strategic External Engagement & Global Congress Strategy: Define and lead the global Hematology strategy for major scientific congresses and strategic external engagement moments. Turn key scientific meetings into high-impact opportunities for scientific engagement, thought leadership, relationship building, insight generation and AZ visibility. Develop integrated objectives and engagement strategies with Commercial, Medical, R&D, Advocacy and regional teams. Ensure external engagement insights are systematically captured, synthesized and translated into actionable recommendations for the Franchise.
Drive Portfolio Impact & Build Future Capability: Partner with therapeutic area and asset teams to ensure Customer Engagement and Advocacy support portfolio priorities, launches, lifecycle milestones and long-term value creation. Identify opportunities to leverage customer relationships, insights and engagement platforms across therapeutic areas while maintaining disease-specific relevance. Support key portfolio milestones through strategic Customer Engagement and Advocacy. Lead the Customer Engagement and Advocacy capability model, including frameworks, tools, standards, dashboards and best practices. Build capabilities and develop talent across Global, Regions and Markets to support the Hematology Franchise ambition. Influence and align stakeholders across the global matrix to drive execution and measurable outcomes.